For those in the know, the AMT has become the tax equivalent of the boogeyman. Unfortunately, unlike the object of children's nightmares, this lurking threat is all too real. Calculated alongside ordinary income tax for all households, the AMT erases many standard deductions to which Americans have become accustomed. Taxpayers then must pay whichever tax is higher.
The president, president-elect, and executive vice president of the American Academy of Ophthalmology (AAO) recently offered a "state-of-the-profession" message during the opening session of the AAO annual meeting in Chicago. All three executives shared in a celebration of past achievements, current conditions, and future opportunities in ophthalmology
Paris—Fovea Pharmaceuticals SA, a biopharmaceutical company working to discover, develop, and commercialize drugs to treat retinal diseases, announced the closing of a $25 million equity financing round.
If you're inclined to let your accountant do all the worrying about your professional and personal income taxes, you could be making a costly mistake.
Alpharetta, GA—When the global management of Novartis decided to shut down its ophthalmic operations in Duluth, GA, in early 2003 and relocate to New Jersey, Dan Myers, then president of Novartis Ophthalmics/North America, thought he would leave the company and have the next 6 months to relax.
Doctors have clearly discovered the lure of pre-tax savings, and are making the most of opportunities to sock away as much as they can.
Montreal—Intravitreal triamcinolone acetonide (Kenalog, Bristol-Myers Squibb) is effective in the treatment of macular diseases but is associated with complications such as ocular hypertension, endophthalmitis, intraocular inflammation, and progression of cataract. While the long-term effects of the drug still need to be determined, the drug appears to be safe for treating macular diseases.
It is extremely important to get a sense of confidence in your planning, because it not only affects your future, but has an impact on your life right now.
For the last 15 years, the Grandes have been lecturing on retirement planning for the Johns Hopkins Medical University School of Medicine's Current Concepts in Ophthalmology meetings.
Rochester, NY—Increased demand for Bausch & Lomb's PureVision SVS contact lens has the company potentially shifting gears away from its PureVision Toric lens, which was to be introduced in the United States this summer.